+

CN112569457B - Continuous administration cyst tube system - Google Patents

Continuous administration cyst tube system Download PDF

Info

Publication number
CN112569457B
CN112569457B CN202011451940.4A CN202011451940A CN112569457B CN 112569457 B CN112569457 B CN 112569457B CN 202011451940 A CN202011451940 A CN 202011451940A CN 112569457 B CN112569457 B CN 112569457B
Authority
CN
China
Prior art keywords
blind end
sac
drainage tube
flow
shaped blind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011451940.4A
Other languages
Chinese (zh)
Other versions
CN112569457A (en
Inventor
刘忠军
景泽昊
王杰栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University Third Hospital Peking University Third Clinical Medical College
Original Assignee
Peking University Third Hospital Peking University Third Clinical Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University Third Hospital Peking University Third Clinical Medical College filed Critical Peking University Third Hospital Peking University Third Clinical Medical College
Priority to CN202011451940.4A priority Critical patent/CN112569457B/en
Publication of CN112569457A publication Critical patent/CN112569457A/en
Application granted granted Critical
Publication of CN112569457B publication Critical patent/CN112569457B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

本发明涉及一种持续给药囊管系统,包括囊状盲端、限流通道和引流管,囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;限流通道密封连接在囊状盲端和引流管之间;囊状盲端用于储存流体药物并通过限流通道和引流管向治疗靶点持续灌流流体药物;限流通道用于限定从囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端的持续灌流。

The invention relates to a continuous drug delivery sac system, which includes a sac-shaped blind end, a flow-limiting channel and a drainage tube. The sac-shaped blind end is made of elastic and expandable material and can be buried under the skin; the flow-limiting channel is sealed and connected to the sac-shaped blind end. Between the blind end and the drainage tube; the sac-shaped blind end is used to store fluid drugs and continuously perfuse fluid drugs to the treatment target through the flow-limiting channel and the drainage tube; the flow-limiting channel is used to limit the flow of fluid drugs out of the sac-shaped blind end. The flow rate and flow rate are such that the fluid medicine injected into the sac-shaped blind end is temporarily retained in the sac-shaped blind end, and then the sac-shaped blind end is expanded, thereby maintaining the continuous flow of the fluid medicine from the sac-shaped blind end to the open end of the drainage tube. perfusion.

Description

一种持续给药囊管系统A continuous drug delivery capsule system

技术领域Technical field

本发明涉及医疗器械技术领域,具体涉及一种持续给药囊管系统。The invention relates to the technical field of medical devices, and in particular to a continuous drug delivery capsule system.

背景技术Background technique

目前,化疗药的传统给药方式主要为静脉注射,该方法无法精准杀伤肿瘤,因此具有效率低下、副作用大等缺点。局部给药是解决上述问题比较好的改良方案,包括:一次性药物局部注射、多次穿刺局部给药等、经引流管局部注药等。但是,上述局部给药方法都有各自的缺点,限制了其临床应用。At present, the traditional way of administering chemotherapy drugs is mainly intravenous injection. This method cannot accurately kill tumors, so it has shortcomings such as low efficiency and high side effects. Local administration is a better improved solution to solve the above problems, including: one-time local injection of drugs, multiple punctures for local administration, etc., local injection of drugs through drainage tubes, etc. However, the above local administration methods have their own shortcomings, which limit their clinical application.

各种局部给药方法的缺点包括:一次性药物局部注射由于体内空间有限,因此给药总剂量低、作用时间短;多次穿刺局部给药需要CT辅助及较高的技术水平,而且风险较大,很难推广;经引流管局部注药易导致体外细菌通过引流管外口进入体内,有极大的深部感染风险。因此开发新的局部给药装置,以避免上述缺点,具有十分重要的临床意义。The disadvantages of various local drug delivery methods include: due to the limited space in the body, the total dose of one-time local drug injection is low and the action time is short; multiple puncture local drug administration requires CT assistance and a higher technical level, and the risk is relatively high It is large and difficult to promote; local injection through the drainage tube can easily cause bacteria outside the body to enter the body through the outer opening of the drainage tube, posing a great risk of deep infection. Therefore, it is of great clinical significance to develop new local drug delivery devices to avoid the above shortcomings.

发明内容Contents of the invention

本发明旨在提供一种新型的持续给药囊管系统,以解决现有技术中局部给药方案面临的载药量小、作用时间短、穿刺操作风险大、易造成深部感染等问题。The present invention aims to provide a new type of continuous drug delivery capsule system to solve the problems of small drug loading, short action time, high risk of puncture operation, easy to cause deep infection and other problems faced by the local drug delivery scheme in the existing technology.

本发明的目的是解决现有技术的不足,提供一种新型的持续给药囊管系统,包括囊状盲端、限流通道和引流管,所述的囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;所述的限流通道密封连接在囊状盲端和引流管之间;所述的囊状盲端用于储存流体药物并通过限流通道和引流管向治疗靶点持续灌流所述的流体药物;所述的限流通道用于限定从所述的囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端的持续灌流。The purpose of the present invention is to solve the deficiencies of the prior art and provide a new type of continuous drug delivery sac system, which includes a sac-shaped blind end, a flow-limiting channel and a drainage tube. The sac-shaped blind end is made of elastic and expandable material. It is made and can be buried under the skin; the flow-limiting channel is sealed and connected between the sac-like blind end and the drainage tube; the sac-like blind end is used to store fluid medicine and deliver it to the treatment target through the flow-limiting channel and the drainage tube. The fluid medicine is continuously perfused; the flow-limiting channel is used to limit the flow rate and flow rate of the fluid medicine flowing out from the sac-shaped blind end, so that the fluid medicine injected into the sac-shaped blind end is temporarily retained in the sac. into the blind end of the sac, thereby inflating the blind end of the sac to maintain continuous perfusion of fluid medicine from the blind end of the sac to the open end of the drainage tube.

所述的治疗靶点包括人体内肿瘤周围或者是感染病灶周围的位置。The therapeutic targets include locations around tumors or infection lesions in the human body.

所述的引流管的开口端植入在人体深部的治疗靶点。The open end of the drainage tube is implanted into a therapeutic target deep in the human body.

所述的囊状盲端埋藏于皮下以后,允许通过简单的皮下、肌肉或静脉注射技术向埋藏于皮下的囊状盲端注射药物。After the cystic blind end is buried under the skin, drugs can be injected into the cystic blind end buried under the skin through simple subcutaneous, intramuscular or intravenous injection techniques.

优选地,所述的囊状盲端允许采用普通的肌肉注射针头、皮下注射针头或静脉输液针头向埋藏于皮下的囊状盲端注射药物。Preferably, the cystic blind end allows the use of ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles to inject drugs into the cystic blind end buried under the skin.

所述的囊状盲端设置有一个或多个。There are one or more bladder-shaped blind ends.

所述的开口端设置有一个或多个。There are one or more said open ends.

所述的囊状盲端、限流通道和引流管采用弹性硅胶做成。The sac-shaped blind end, flow-limiting channel and drainage tube are made of elastic silicone.

所述的囊状盲端能够储药10ml至400ml。The cystic blind end can store 10ml to 400ml of medicine.

所述的限流通道使得从所述的囊状盲端流出的流体药物的限制流速为0.5ml/天至10ml/天,平均给药周期为1周至1年。The flow-limiting channel allows the restricted flow rate of the fluid medicine flowing out from the sac-shaped blind end to be 0.5 ml/day to 10 ml/day, and the average administration period is 1 week to 1 year.

有益效果beneficial effects

与现有技术相比,本发明的有益效果是:Compared with the prior art, the beneficial effects of the present invention are:

本发明所述的持续给药囊管系统通过将传统硅胶引流管的一端做成膨大的囊状盲端,用于埋植于皮下,以储存药物并接受体外注药,应用过程中,埋藏于皮下的囊状盲端可以容纳较多药物,从而解决一次性药物局部注射所面临的载药量小的问题;由于本发明所述的持续给药囊管系统可用于反复多次给药,并且限流通道可以维持药物的持续灌流,避免了一次性药物局部注射所面临的作用时间短的问题;在使用本发明所述的持续给药囊管系统时,用于局部给药的穿刺操作与常规的皮下、肌肉或静脉注射操作类似,无需CT辅助,避免了多次穿刺局部给药所面临的穿刺操作难度高、风险大的问题;本发明所述的持续给药囊管系统的囊状盲端埋藏于皮下,无体外部分,减少了体外细菌通过引流管外口进入体内造成深部感染的风险。The continuous drug administration capsule system of the present invention makes one end of the traditional silicone drainage tube into an enlarged capsule-shaped blind end, which is used to be buried under the skin to store drugs and receive in vitro injection. During the application process, it is buried in the The subcutaneous blind end of the capsule can accommodate more drugs, thereby solving the problem of small drug loading faced by one-time local injection of drugs; because the continuous drug delivery capsule system of the present invention can be used for repeated administration, and The flow-limiting channel can maintain continuous perfusion of drugs and avoid the problem of short action time faced by local injection of one-time drugs; when using the continuous drug delivery capsule system of the present invention, the puncture operation for local drug administration and Conventional subcutaneous, intramuscular or intravenous injection operations are similar and do not require CT assistance, thus avoiding the problems of high difficulty and high risk of puncture operations faced by multiple punctures for local administration; the capsule-shaped continuous drug delivery sac system of the present invention The blind end is buried under the skin and has no external part, which reduces the risk of external bacteria entering the body through the external opening of the drainage tube and causing deep infection.

附图说明Description of the drawings

附图用来提供对本发明技术方案的进一步理解,并且构成说明书的一部分,与本申请的具体实施方式一起用于解释本发明的技术方案,并不构成对本发明技术方案的限制。The drawings are used to provide a further understanding of the technical solution of the present invention, and constitute a part of the description. They are used to explain the technical solution of the present invention together with the specific embodiments of the present application, and do not constitute a limitation of the technical solution of the present invention.

图1是本发明所述的持续给药囊管系统的整体结构示意图。Figure 1 is a schematic diagram of the overall structure of the continuous drug delivery capsule system of the present invention.

具体实施方式Detailed ways

在下文中更详细地描述了本发明以有助于对本发明的理解。The invention is described in more detail below to facilitate understanding of the invention.

如图1所示,本发明所述的持续给药囊管系统包括囊状盲端1、限流通道2和引流管3,所述的囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;所述的限流通道2密封连接在囊状盲端1和引流管3之间;所述的囊状盲端用于储存流体药物并通过限流通道2和引流管3向治疗靶点持续灌流所述的流体药物;所述的限流通道2用于限定从所述的囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端4的持续灌流。As shown in Figure 1, the continuous drug delivery bladder system of the present invention includes a bladder-shaped blind end 1, a flow-limiting channel 2 and a drainage tube 3. The bladder-shaped blind end is made of elastic and expandable material and can be buried. subcutaneously; the flow-limiting channel 2 is sealingly connected between the sac-like blind end 1 and the drainage tube 3; the sac-like blind end is used to store fluid medicine and deliver it to the treatment target through the flow-restricting channel 2 and the drainage tube 3 The fluid medicine is continuously perfused at one point; the flow-limiting channel 2 is used to limit the flow rate and flow rate of the fluid medicine flowing out from the sac-shaped blind end, so that the fluid medicine injected into the sac-shaped blind end temporarily remains. In the sac-like blind end, the sac-like blind end is then expanded to maintain continuous perfusion of fluid medicine from the sac-shaped blind end to the open end 4 of the drainage tube.

所述的治疗靶点包括人体内肿瘤周围或者是感染病灶周围的位置。The therapeutic targets include locations around tumors or infection lesions in the human body.

所述的引流管的开口端植入在人体深部的治疗靶点。The open end of the drainage tube is implanted into a therapeutic target deep in the human body.

所述的囊状盲端埋藏于皮下以后,允许通过简单的皮下、肌肉或静脉注射技术向埋藏于皮下的囊状盲端注射药物。After the cystic blind end is buried under the skin, drugs can be injected into the cystic blind end buried under the skin through simple subcutaneous, intramuscular or intravenous injection techniques.

优选地,所述的囊状盲端允许采用普通的肌肉注射针头、皮下注射针头或静脉输液针头向埋藏于皮下的囊状盲端注射药物。Preferably, the cystic blind end allows the use of ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles to inject drugs into the cystic blind end buried under the skin.

进一步优选地,所述的囊状盲端设置有一个或多个,所述的开口端也设置有一个或多个,以实现一种或多种药物的载药和递送。It is further preferred that one or more sac-like blind ends are provided, and one or more open ends are also provided, to achieve drug loading and delivery of one or more drugs.

所述的囊状盲端、限流通道和引流管采用弹性硅胶做成。The sac-shaped blind end, flow-limiting channel and drainage tube are made of elastic silicone.

本发明所述的持续给药囊管系统是在传统硅胶引流管的基础上改进而来,只保留传统引流管的体内部分,并且将引流管浅部一端用弹性硅胶做成可膨胀的囊状盲端,囊状盲端与引流管之间留有一狭窄的限流通道,该限流通道仅能让液体缓慢流过(囊状盲端储药约10-400ml,限流通道使得限制流速0.5-10ml/天,平均给药周期约1周-1年),以使注入膨胀盲端的药物暂时留存,继而使囊状盲端膨胀,从而维持药物从盲端向开口端的持续灌流。使用者可按照传统引流管的植入方式,将本发明的开口端植入深部的治疗靶点(如肿瘤周围或者是感染病灶周围),然后将本发明的囊状盲端埋藏于皮下。术后,只需利用普通的肌肉注射针头、皮下注射针头或静脉输液针头,采用简单的皮下、肌肉或静脉注射技术,即可向埋藏于皮下的囊状盲端注射药物;注入囊状盲端的药物可经过引流管进入深部的治疗靶点,达到精准治疗的效果。The continuous drug delivery capsule system of the present invention is improved on the basis of traditional silicone drainage tubes. Only the internal body part of the traditional drainage tube is retained, and the shallow end of the drainage tube is made into an expandable bladder shape with elastic silicone. Blind end, there is a narrow flow-limiting channel between the sac-like blind end and the drainage tube, which can only allow liquid to flow slowly (the sac-like blind end stores about 10-400ml of medicine, and the flow-limiting channel limits the flow rate to 0.5 -10ml/day, the average administration period is about 1 week to 1 year), so that the drug injected into the expanded blind end is temporarily retained, and then the cystic blind end is expanded to maintain continuous perfusion of the drug from the blind end to the open end. The user can implant the open end of the present invention into a deep treatment target (such as around a tumor or an infected lesion) according to the traditional drainage tube implantation method, and then bury the cystic blind end of the present invention under the skin. After surgery, you only need to use ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles, and use simple subcutaneous, intramuscular or intravenous injection techniques to inject drugs into the cystic blind end buried under the skin; inject drugs into the cystic blind end. Drugs can enter deep treatment targets through the drainage tube to achieve precise treatment effects.

本发明中所述囊状盲端、限流通道和引流管的材料不限于硅胶材料,其他可用于人体植入的材料均可作为硅胶的替代材料。The materials of the sac-shaped blind end, the flow-limiting channel and the drainage tube in the present invention are not limited to silicone materials, and other materials that can be used for human body implantation can be used as substitute materials for silicone.

以上描述了本发明优选实施方式,然其并非用以限定本发明。本领域技术人员对在此公开的实施方案可进行并不偏离本发明范畴和精神的改进和变化。The preferred embodiments of the present invention have been described above, but they are not intended to limit the present invention. Those skilled in the art may make modifications and changes to the embodiments disclosed herein without departing from the scope and spirit of the invention.

Claims (1)

1.一种持续给药囊管系统,其特征在于,所述的持续给药囊管系统是在传统硅胶引流管的基础上改进而来,只保留传统引流管的体内部分,并且将引流管浅部一端做成可膨胀的囊状盲端,囊状盲端与引流管之间留有一狭窄的限流通道,以使注入膨胀盲端的药物暂时留存,继而使囊状盲端膨胀,从而维持药物从盲端向开口端的持续灌流;所述的囊状盲端与所述的限流通道之间不通过任何连接部件地自然过渡连接;1. A continuous drug delivery capsule system, characterized in that the continuous drug delivery capsule system is improved on the basis of traditional silicone drainage tubes, retaining only the body part of the traditional drainage tube, and converting the drainage tube into One end of the shallow part is made into an expandable sac-shaped blind end, and a narrow flow-limiting channel is left between the sac-shaped blind end and the drainage tube, so that the medicine injected into the expanded blind end can be temporarily retained, and then the sac-shaped blind end can be expanded to maintain the function. Continuous perfusion of medicine from the blind end to the open end; a natural transitional connection between the bladder-shaped blind end and the flow-restricting channel without any connecting parts; 所述的持续给药囊管系统包括囊状盲端、限流通道和引流管,所述的囊状盲端采用弹性可膨胀的材质制作,能够埋藏于皮下;所述的限流通道密封连接在囊状盲端和引流管之间;所述的囊状盲端用于储存流体药物并通过限流通道和引流管向治疗靶点持续灌流所述的流体药物;所述的限流通道用于限定从所述的囊状盲端流出的流体药物的流速和流量,以使注入所述囊状盲端的流体药物暂时留存在该囊状盲端中,继而使囊状盲端膨胀,从而维持流体药物从该囊状盲端向引流管的开口端的持续灌流;The continuous drug delivery sac system includes a sac-shaped blind end, a flow-limiting channel and a drainage tube. The sac-shaped blind end is made of elastic and expandable material and can be buried under the skin; the flow-limiting channel is sealed and connected. Between the cystic blind end and the drainage tube; the cystic blind end is used to store fluid medicine and continuously perfuse the fluid medicine to the treatment target through the flow-limiting channel and the drainage tube; the flow-limiting channel is used for The flow rate and flow rate of the fluid medicine flowing out from the sac-shaped blind end are limited, so that the fluid medicament injected into the sac-shaped blind end is temporarily retained in the sac-shaped blind end, and then the sac-shaped blind end is expanded, thereby maintaining Continuous perfusion of fluid medicine from the blind end of the sac to the open end of the drainage tube; 所述的囊状盲端、限流通道和引流管采用弹性硅胶做成;The sac-shaped blind end, flow-limiting channel and drainage tube are made of elastic silicone; 所述的囊状盲端能够储药10ml至400ml;The cystic blind end can store 10ml to 400ml of medicine; 所述的限流通道使得从所述的囊状盲端流出的流体药物的限制流速为0.5 ml/天至10ml/天,平均给药周期为1周至1年;The flow-limiting channel allows the restricted flow rate of the fluid medicine flowing out from the sac-shaped blind end to be 0.5 ml/day to 10 ml/day, and the average dosing period is 1 week to 1 year; 所述的囊状盲端设置有一个或多个;One or more bladder-shaped blind ends are provided; 所述的开口端设置有一个或多个;There are one or more said open ends; 所述的治疗靶点包括人体内肿瘤周围或者是感染病灶周围的位置;The treatment targets include locations around tumors or infection lesions in the human body; 所述的引流管的开口端植入在人体深部的治疗靶点;The open end of the drainage tube is implanted at a therapeutic target deep in the human body; 所述的囊状盲端埋藏于皮下以后,允许通过简单的皮下、肌肉或静脉注射技术向埋藏于皮下的囊状盲端注射药物;After the cystic blind end is buried under the skin, drugs can be injected into the cystic blind end buried under the skin through simple subcutaneous, intramuscular or intravenous injection techniques; 所述的囊状盲端允许采用普通的肌肉注射针头、皮下注射针头或静脉输液针头向埋藏于皮下的囊状盲端注射药物,The described cystic blind end allows the use of ordinary intramuscular injection needles, hypodermic injection needles or intravenous infusion needles to inject drugs into the cystic blind end buried under the skin. 使用者能够按照传统引流管的植入方式,将所述的开口端植入深部的治疗靶点,然后将所述的囊状盲端埋藏于皮下;术后,只需利用普通的肌肉注射针头、皮下注射针头或静脉输液针头,采用简单的皮下、肌肉或静脉注射技术,就能够向埋藏于皮下的囊状盲端注射药物;注入囊状盲端的药物经过引流管进入深部的治疗靶点,达到精准治疗的效果;所述的持续给药囊管系统的囊状盲端埋藏于皮下,无体外部分,减少了体外细菌通过引流管外口进入体内造成深部感染的风险。The user can implant the open end into the deep treatment target according to the traditional drainage tube implantation method, and then bury the cystic blind end under the skin; after surgery, only use an ordinary intramuscular injection needle , hypodermic injection needle or intravenous infusion needle, using simple subcutaneous, intramuscular or intravenous injection techniques, can inject drugs into the cystic blind end buried under the skin; the drugs injected into the cystic blind end enter the deep treatment target through the drainage tube, The effect of precise treatment is achieved; the sac-shaped blind end of the continuous drug delivery sac system is buried under the skin without an external part, which reduces the risk of external bacteria entering the body through the outer opening of the drainage tube and causing deep infection.
CN202011451940.4A 2020-12-10 2020-12-10 Continuous administration cyst tube system Active CN112569457B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011451940.4A CN112569457B (en) 2020-12-10 2020-12-10 Continuous administration cyst tube system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011451940.4A CN112569457B (en) 2020-12-10 2020-12-10 Continuous administration cyst tube system

Publications (2)

Publication Number Publication Date
CN112569457A CN112569457A (en) 2021-03-30
CN112569457B true CN112569457B (en) 2024-02-13

Family

ID=75131229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011451940.4A Active CN112569457B (en) 2020-12-10 2020-12-10 Continuous administration cyst tube system

Country Status (1)

Country Link
CN (1) CN112569457B (en)

Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1130743A (en) * 1956-08-30 1957-02-11 Flexible containers
US3796217A (en) * 1972-03-10 1974-03-12 Hydr Med Sciences Inc Drug release system
US5688237A (en) * 1995-05-04 1997-11-18 Cedars-Sinai Medical Center Implantable catheter and method of use
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
CN2362514Y (en) * 1998-11-03 2000-02-09 陈军 Embedding type medicine introducing device
US20030014036A1 (en) * 2001-06-12 2003-01-16 Varner Signe Erickson Reservoir device for intraocular drug delivery
US20030078550A1 (en) * 2001-10-22 2003-04-24 Williamson Shobha Devi Implantable pump catheter access port denial device
US20030171401A1 (en) * 1999-03-18 2003-09-11 Johnson Randolph Mellus Devices and methods for pain management
CN2712349Y (en) * 2004-07-12 2005-07-27 郑士全 Subcutaneous implantable sustained-release silica gel rod for antipsychotics
CN1787844A (en) * 2003-05-29 2006-06-14 瑞尼斯豪公司 Implantable pump
CN200998518Y (en) * 2006-11-03 2008-01-02 刘爱军 Micro-wound implanting type radiotherapy bursa
CN101224315A (en) * 2007-12-28 2008-07-23 李楠 Infusion method of multiple medicine and velocity and device thereof
WO2009125181A1 (en) * 2008-04-08 2009-10-15 Epsom And St Helier University Hospitals Nhs Trust Subcutaneous port and catheter
US20110208122A1 (en) * 2010-02-22 2011-08-25 Avraham Shekalim Slow release liquid drug delivery device
CN104857622A (en) * 2015-06-10 2015-08-26 徐增良 Drainage tube
CN106470731A (en) * 2014-03-27 2017-03-01 贝塔O2技术有限公司 Implantable medical device
US20170095653A1 (en) * 2015-10-06 2017-04-06 The Johns Hopkins University Universal microport
CN107735142A (en) * 2015-04-07 2018-02-23 伊哈卜·萨阿卜 Implantable Fluid Delivery Systems
CN107753418A (en) * 2017-11-20 2018-03-06 中国农业科学院北京畜牧兽医研究所 Medicament slow release implants and heeling-in device
CN108042899A (en) * 2018-01-24 2018-05-18 山东百多安医疗器械有限公司 A kind of dual valve implantable drug delivery system
CN110841134A (en) * 2018-08-20 2020-02-28 张海军 Automatic drug delivery system for treating Parkinson's disease
KR20200032023A (en) * 2019-12-06 2020-03-25 주식회사 유니메딕스 Patient controlled drug administration device
CN214633242U (en) * 2020-12-10 2021-11-09 北京大学第三医院(北京大学第三临床医学院) Fully-implanted deep continuous administration silicone capsule tube system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003208901A1 (en) * 2002-02-01 2003-09-02 The Cleveland Clinic Foundation Microinfusion device
US10307581B2 (en) * 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
US20090149838A1 (en) * 2007-12-10 2009-06-11 Cassada David C Subcutaneous Implant System

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1130743A (en) * 1956-08-30 1957-02-11 Flexible containers
US3796217A (en) * 1972-03-10 1974-03-12 Hydr Med Sciences Inc Drug release system
US5688237A (en) * 1995-05-04 1997-11-18 Cedars-Sinai Medical Center Implantable catheter and method of use
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
CN2362514Y (en) * 1998-11-03 2000-02-09 陈军 Embedding type medicine introducing device
US20030171401A1 (en) * 1999-03-18 2003-09-11 Johnson Randolph Mellus Devices and methods for pain management
US20030014036A1 (en) * 2001-06-12 2003-01-16 Varner Signe Erickson Reservoir device for intraocular drug delivery
US20030078550A1 (en) * 2001-10-22 2003-04-24 Williamson Shobha Devi Implantable pump catheter access port denial device
CN1787844A (en) * 2003-05-29 2006-06-14 瑞尼斯豪公司 Implantable pump
CN2712349Y (en) * 2004-07-12 2005-07-27 郑士全 Subcutaneous implantable sustained-release silica gel rod for antipsychotics
CN200998518Y (en) * 2006-11-03 2008-01-02 刘爱军 Micro-wound implanting type radiotherapy bursa
CN101224315A (en) * 2007-12-28 2008-07-23 李楠 Infusion method of multiple medicine and velocity and device thereof
WO2009125181A1 (en) * 2008-04-08 2009-10-15 Epsom And St Helier University Hospitals Nhs Trust Subcutaneous port and catheter
US20110208122A1 (en) * 2010-02-22 2011-08-25 Avraham Shekalim Slow release liquid drug delivery device
CN106470731A (en) * 2014-03-27 2017-03-01 贝塔O2技术有限公司 Implantable medical device
CN107735142A (en) * 2015-04-07 2018-02-23 伊哈卜·萨阿卜 Implantable Fluid Delivery Systems
CN104857622A (en) * 2015-06-10 2015-08-26 徐增良 Drainage tube
US20170095653A1 (en) * 2015-10-06 2017-04-06 The Johns Hopkins University Universal microport
CN107753418A (en) * 2017-11-20 2018-03-06 中国农业科学院北京畜牧兽医研究所 Medicament slow release implants and heeling-in device
CN108042899A (en) * 2018-01-24 2018-05-18 山东百多安医疗器械有限公司 A kind of dual valve implantable drug delivery system
CN110841134A (en) * 2018-08-20 2020-02-28 张海军 Automatic drug delivery system for treating Parkinson's disease
KR20200032023A (en) * 2019-12-06 2020-03-25 주식회사 유니메딕스 Patient controlled drug administration device
CN214633242U (en) * 2020-12-10 2021-11-09 北京大学第三医院(北京大学第三临床医学院) Fully-implanted deep continuous administration silicone capsule tube system

Also Published As

Publication number Publication date
CN112569457A (en) 2021-03-30

Similar Documents

Publication Publication Date Title
AU2017202439B2 (en) Implantable solid-liquid drug delivery apparatus, formulations, and methods of use
AU742061B2 (en) Device for local administration of solid and semisolid formulations, sustained-release formulations for parenteral administration and method of preparation
CN206007700U (en) A kind of full-implantation type venous transfusion port
CN112569457B (en) Continuous administration cyst tube system
CN214633242U (en) Fully-implanted deep continuous administration silicone capsule tube system
CN102151346A (en) Hypodermic implantation type medicine feeder
CN206621657U (en) A kind of elastic micropin containing solvable syringe needle
CN209270606U (en) Orthopedic implantable drug delivery device
CN215426894U (en) Bladder cancer postoperative perfusion device
CN215780558U (en) Improved disposable continuous infusion pump suitable for transarterial administration
CN209630432U (en) A subcutaneous implantable drug delivery device
CN211188555U (en) Subcutaneous implantation type abdominal cavity chemotherapy device
CN202061177U (en) Hypodermic implantation type drug administration device
CN208942082U (en) Drug delivery device under a kind of simple hysteroscope
US20070073239A1 (en) Catheter device
CN208974039U (en) Bone joint infection drug delivery device
CN100387315C (en) Minimally invasive treatment tube for mammary abscess
WO2006108336A1 (en) Implantable administrating catheter
CN222752413U (en) Subcutaneous implantation type bladder drug delivery device
CN2098297U (en) Multifunctional medical capsule catheter
CN208785472U (en) A kind of Internal Medicine-Oncology drug delivery device
CN214911512U (en) Disposable low-pressure enemator
CN223208815U (en) Radiopharmaceutical injection device
CN214550516U (en) An implantable intraperitoneal subcutaneous chemotherapy device
CN204910431U (en) Heart in situ perfusion pipe

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载